AI
By
Qure.ai Secures Landmark FDA Clearance for qXR-Detect, Cementing AI Leadership in Global Diagnostics—Brainlab Partnership Signals Agentic AI Workflow Revolution
Mumbai, India – March 4, 2026 – Qure.ai, a global leader in AI-powered radiology, today celebrated FDA clearance for…
RecovryAI’s FDA Breakthrough: Post-Op AI Agents’ 85% Complication Prediction or Wearable Hype Meets Reality?
RecovryAI snared FDA Breakthrough Device Designation on March 4, 2026, for its physician-prescribed Virtual Care Assistants—AI agents that…
Ardent Health’s Hellocare.ai Virtual Nursing Play: 20% Readmission Slash or AI Overreach in Care?
Ardent Health’s March 3-4, 2026, partnership with Hellocare.ai deploys AI modules for virtual nursing, telehealth, and real-time patient…
VA’s Nationwide Ambient AI Scribe Rollout: Burnout Buster or Documentation Digitized Trap?
The U.S. Department of Veterans Affairs on March 4, 2026, greenlit ambient scribe AI from Knowtex and Abridge…
How Does Sanofi Transform Immunology Dominance Into €20+ Billion Revenue Through 2030?
Sanofi masterminds a “multi-indication immunology powerhouse” strategy, surgically channeling R&D toward 12 blockbuster candidates (3 “pipeline-in-a-product” assets exceeding €5B peak…
How Does Novo Nordisk Transform Metabolic Leadership Into Multi-Billion Dollar Dominance Through 2030?
Novo Nordisk executes a “multi-mechanism obesity fortress” strategy under new CEO Mike Doustdar, reallocating R&D firepower from discontinued cell therapies…
